- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ANTERIS TECHNOLOGIES GLOBAL Aktie jetzt für 0€ handeln | |||||
| 24.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Application for quotation of securities - AVR | 4 | ASX | ||
| 24.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | 1 | ASX | ||
| 24.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Change of Director's Interest Notice | 2 | ASX | ||
| 18.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Final Director's Interest Notice | 3 | ASX | ||
| 15.12.25 | Anteris Technologies Global Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Board Resignation | - | ASX | ||
| 12.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | - | ASX | ||
| 10.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Change of Director's Interest Notice | - | ASX | ||
| 10.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | - | ASX | ||
| 05.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | 1 | ASX | ||
| 04.12.25 | Anteris Technologies: Aktionäre billigen Vorstandswahlen und Aktienvergütungen | 3 | Investing.com Deutsch | ||
| 04.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Results of Meeting | - | ASX | ||
| 04.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Annual Meeting CEO Presentation | 1 | ASX | ||
| 03.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Pause in Trading | - | ASX | ||
| 02.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification of cessation of securities - AVR | - | ASX | ||
| 01.12.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: Termination of Agreement | - | ASX | ||
| 01.12.25 | Anteris Technologies beendet Liefervereinbarung mit 4C Medical Technologies | 2 | Investing.com Deutsch | ||
| 01.12.25 | Anteris Technologies Global Corp. - 8-K, Current Report | - | SEC Filings | ||
| 26.11.25 | ANTERIS TECHNOLOGIES GLOBAL CORP.: SEC Form S-1 Registration Statement | 1 | ASX | ||
| 26.11.25 | Anteris Technologies Global Corp. - S-1, General form for registration of securities | - | SEC Filings |
1 2 3 4 5 Weiter >>
95 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,080 | +1,27 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| FAMICORD | 6,150 | +0,82 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,880 | -0,35 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
| PLUS THERAPEUTICS | 0,511 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ in Leptomeningeal Metastases | HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| MEDICLIN | 3,700 | +3,35 % | EQS-News: MEDICLIN AG: Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025 | EQS-News: MEDICLIN AG
/ Schlagwort(e): Personalie
Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025
16.12.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,537 | -0,74 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy | Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval
SEATTLE... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,542 | -1,66 % | PA GOODDOCTOR (01833): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION ... | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 9,530 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| BETA BIONICS | 30,470 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 130,06 | +1,61 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| HEARTFLOW | 29,150 | -3,51 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,760 | +2,70 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,170 | -2,62 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| SIGHT SCIENCES | 7,930 | -0,88 % | Sight Sciences, Inc.: Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer | MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing... ► Artikel lesen |
Das Unternehmen ANTERIS TECHNOLOGIES GLOBAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 4,990 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ANTERIS TECHNOLOGIES GLOBAL CORP finden Sie auf Wallstreet Online.